Combination Therapies Reduce Treg Functions in CHC Patients
by Caleb Sooknanan ’20 Regulatory T-Cells, or Tregs, are important contributors to the development of chronic hepatitis C (CHC) infections in patients. Oral antiviral agents are the most common treatments for CHC infections in most Western countries, while pegylated interferon (PEG-IFN) treatment is the standard therapy in many Asian countries. PEG-IFNs are interferons that attach to polyethylene glycol molecules to trigger sustained virological responses (SVR) … Continue reading Combination Therapies Reduce Treg Functions in CHC Patients

